Papers

1

Total Citations

12

H-Index

1

About

Dr. Chaowei Mu is a pioneering interventional cardiologist whose work centers on the advancement of robotic-assisted percutaneous coronary intervention (R-PCI), particularly within the Asian healthcare context. His most cited study, "Feasibility and safety of robotic PCI in China: first in man experience in Asia" (2019), represents a landmark contribution to the field. This work provided the first clinical evidence in Asia demonstrating that a second-generation robotic system could be used safely and effectively for coronary interventions. By meticulously evaluating procedural feasibility and patient outcomes, Dr. Mu established a critical proof-of-concept that has helped pave the way for broader adoption of robotic precision in interventional cardiology across the region. His research directly addresses the need for more accurate lesion measurement and enhanced procedural control, offering tangible benefits in reducing radiation exposure and improving stent placement accuracy. With 12 citations, this foundational study continues to influence both clinical practice and the development of next-generation robotic platforms. Dr. Mu’s work stands at the intersection of innovation and patient safety, marking him as a key figure in the global shift toward minimally invasive, technology-driven cardiac care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility and safety of robotic PCI in China: first in man experience in Asia.
12 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago